February 2020 Briefing – Pediatrics
Here are what the editors at HealthDay consider to be the most important developments in Pediatrics for February 2020. This roundup includes the latest...
HIV-Infected Youth Less Likely to Achieve Viral Suppression
Findings seen in large national sample of youth despite similar rates of linkage to care as adults
Age of Onset May Affect Clinical Outcomes for MS Patients on DMT
Age-dependent differences seen for clinical outcomes in response to disease-modifying therapy
Video Game-Like Intervention May Aid Children With ADHD
Attentional functioning improved in four-week trial for children receiving intervention versus control
NIH Toolbox Cognitive Battery Valid in Intellectual Disability
NIHTB-CB is reliable and valid for children and young adults with a mental age older than 5.0 years
Recommendations Issued for R/R Pediatric Hodgkin Lymphoma
Recommendations developed for salvage therapy for pediatric patients with first relapse/refractory cHL
Influence of Politics Has Not Waned in Opinions About ACA
Partisan divisions in favorable opinion of the ACA have gotten larger rather than smaller over time
States Launch Investigation of Juul Labs
Investigation will include whether Juul made misleading claims about nicotine content in the devices
Tax on Sweetened Beverages Reduced Sales Volume in Chicago
Decrease was more than 20 percent even when accounting for cross-border shopping
Guidance Issued for Food Intake in Inflammatory Bowel Disease
Evidence insufficient for recommending changes in diet for complex carbs, refined sugars, wheat, gluten
